This page contains a Flash digital edition of a book.
Sciences, Medicine & Engineering


Laverne Antrobus


Consultant Child and Educational Psychologist


Laverne specialises in off ering treatment to children who have emotional, behavioural and psychiatric diffi culties and in helping their parents to manage their needs. With more than 17 years of experience her counsel is widely sought. Laverne has fronted her own BBC4 series, Growing Children on Autism, OCD and Dyslexia. She has also been a presenter on the award-winning show House of Tiny Tearaways, as well as other shows such as Little Angels and Teen Angels. Her advice is regularly sought on GMTV and BBC Breakfast. She authored Ain’t Misbehavin’, a guide for parents, and also works as a senior psychologist at London’s Tavistock Clinic. She recently fi lmed a Horizon programme that looked at how attitudes towards mothering have changed. Laverne has also worked in South Africa over the past few years for the charity she chairs, ‘Siya Phulaphula’ (We Listen), supporting mental health practitioners in rural communities. She has also recorded a programme about South Africa’s Phelophepa Health Train – a train that brings low-cost medical treatment, in the form of a clinic, to remote communities in South Africa that might not otherwise have easy access to doctors.


Dr Akintunde Bello


Senior Director and Clinical Pharmacology Group Leader, Oncology Business Unit, Pfi zer Inc


Tunde is a senior director and a clinical pharmacology group leader in the oncology business unit of Pfi zer, the world’s largest pharmaceuticals company by revenues. Over his distinguished, 20-year career, Tunde has played key roles in the development, approval and life-cycle management of drugs for the treatment of diseases across several therapeutic areas (including oncology, pain and infl ammation and infectious disease). He has held several senior positions at the companies he has worked for. Most recently, he was a core member of the clinical development team that developed Xalkori, a treatment for a rare form of lung cancer. Born in west London, he holds a PhD in pharmaceutical sciences from King’s College, University of London. Among a long list of work-related activities, Tunde represents Pfi zer on an industry- wide consortium on drug innovation and he also lectures on the clinical phases of drug development at the US’s annual Drug Development Boot Camp. In addition, he is a member of the American Association of Pharmaceutical Scientists and the Pfi zer African American Leadership Network, which provides guidance and mentoring to colleagues of colour across the company.


Dr Yvonne Greenstreet


Senior Vice-President and Head of Medicines Development for the Specialty Care Business Unit, Pfi zer


Yvonne is one of the most infl uential people in the pharmaceuticals sector globally. Her current role, which she took up in February 2011, means that she has responsibility for leading the global development portfolio of Pfi zer, the world’s largest pharmaceuticals company by revenues, and ensuring this development’s alignment with the group’s speciality care strategic objectives. She has overseen major developments in drugs to counter sickle cell and Alzheimer’s. Yvonne joined Pfi zer aſt er an 18-year career with GlaxoSmithKline, where she most recently was senior vice-president and chief of strategy of R&D. At GSK, she had been responsible for leading the development of small molecules and biologics in several therapeutic areas, including musculoskeletal, immunology/infl ammation, gastrointestinal, urology, ophthalmology and anti-infectives. She had also been responsible for clinical development and medical aff airs for GSK’s European unit. Before joining GSK, Yvonne had practiced medicine in the National Health Service and had gained experience at a number of leading teaching hospitals in London. She holds a degree in medicine from the University of Leeds and an MBA from INSEAD, which is in Fountainbleau, France.


Joy Odili


Consultant Plastic, Reconstructive and Aesthetic Surgeon


Joy is Britain’s fi rst black female consultant plastic surgeon and boasts 15 years of experience in the fi eld. She studied at the Glasgow University Medical School and then did further training at a number of London’s top plastic surgery units before being appointed, in 2009, as a consultant at St George’s Hospital, which is in Tooting. She holds a prestigious Hunterian professorship from the Royal College of Surgeons for her postgraduate research into malignant melanoma, which she has presented nationally and internationally. She is still active in melanoma research and is part of INSPECT, a pan-European database for skin cancer treatment using electrochemotherapy. Joy is also a member of the Government Melanoma Taskforce, a panel of skin cancer and melanoma specialists convened to fi nd strategies to tackle the increasing incidences and rising mortality rates of the disease. While much of her practice deals with skin oncology, Joy is also deeply involved in the education of undergraduate students. She is a member of the Plastic Surgery Training Committee and is involved in the training and recruitment of junior doctors interested in plastic surgery. She is actively involved in open days that introduce schoolchildren and medical students to plastic surgery as a career.


WWW.POWERFUL-MEDIA.COM | POWERLIST 2013 55


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120